journal
https://read.qxmd.com/read/37532227/starfield-pattern-on-brain-mri-in-a-patient-with-duchenne-muscular-dystrophy
#61
JOURNAL ARTICLE
Vivien Xie, Dana Harrar, Jonathan Murnick, Diana Bharucha-Goebel, Kuntal Sen
No abstract text is available yet for this article.
August 2, 2023: Neuropediatrics
https://read.qxmd.com/read/36996861/effects-of-the-covid-19-pandemic-on-access-to-education-and-social-participation-in-children-and-adolescents-with-duchenne-muscular-dystrophy-in-switzerland
#62
JOURNAL ARTICLE
Bettina C Henzi, Dominique Baumann, Sarah J Erni, Nadine Lötscher, Anne Tscherter, Andrea Klein
Two-thirds of patients with Duchenne muscular dystrophy (DMD) have cognitive and neuropsychiatric problems. Concerning their quality of life, negative factors are the lack of qualifying education and social participation in sporting and leisure activities. Adapted assistance in education and participation in social life are thus important. During the coronavirus disease 2019 (COVID-19) pandemic, the pediatric population was less severely impacted by the disease, but by the restrictions associated. The aim of this study was to evaluate the impact of the COVID-19 pandemic regarding access to education and social participation for young patients with DMD in Switzerland...
August 2023: Neuropediatrics
https://read.qxmd.com/read/37467773/use-of-sodium-channel-blockers-in-the-thr226met-pathologic-variant-of-scn1a-a-case-report
#63
JOURNAL ARTICLE
Brenda Carolina Najera Chavez, Lea Seeber, Klaus Goldhahn, Axel Panzer
The Thr226Met pathologic variant of the SCN1A gene has been associated with the clinical development of an early infantile developmental and epileptic encephalopathy (EIDEE) different from Dravet Syndrome. The electrophysiological mechanisms of the mutated channel lead to a paradoxical gain and loss of function. The use of sodium channel blockers (SCB) that counteract this gain of function has been described in previous studies and they can be safely administered to patients carrying mutations in other sodium-channel subtypes without causing a worsening of seizures...
July 19, 2023: Neuropediatrics
https://read.qxmd.com/read/37236246/duchenne-muscular-dystrophy-fatigue-trajectories
#64
JOURNAL ARTICLE
Yi Sally Wei, Mona Hnaini, Basmah ElAloul, Eugenio Zapata, Craig Campbell
INTRODUCTION:  Children with Duchenne muscular dystrophy (DMD) are at risk of experiencing fatigue that negatively impacts their health-related quality of life (HRQoL). This study aimed to assess the association between fatigue and HRQoL, by examining fatigue trajectories over 48 weeks, and assessing factors associated with these fatigue trajectories. METHODS:  The study sample consisted of 173 DMD subjects enrolled in a 48-week-long phase 2 clinical trial (NCT00592553) for a novel therapeutic who were between the ages of 5 and 16 years...
July 4, 2023: Neuropediatrics
https://read.qxmd.com/read/37343586/a-novel-de-novo-heterozygous-mutation-in-the-son-gene-associated-to-septo-optic-dysplasia-a-new-phenotype
#65
JOURNAL ARTICLE
Ludovica Pasca, Ludovica Pasca, Davide Politano, Anna Cavallini, Elena Panzeri, Maria Cristina Vigone, Cristina Baldoli, Marco Abbate, Gaia Kullman, Susan Marelli, Gabriella Pozzobon, Renara Nacinovich, Maria Teresa Bassi, Romina Romaniello
INTRODUCTION: septo-optic dysplasia (SOD) syndrome is a rare congenital disorder characterized by a classic triad of optic nerve/chiasm hypoplasia, agenesis of septum pellucidum and corpus callosum, and hypoplasia of the hypothalamic-pituitary axis. CASE PRESENTATION: herein we report the clinical case of 2-year-old boy presenting with psychomotor delay, nystagmus, congenital hypothyroidism, and a clinically relevant growth delay. The neuroradiological examination showed partial segmental agenesis of the corpus callosum, agenesis of the septum pellucidum, optic nerve hypoplasia (ONH), and a small pituitary gland with a small median pituitary stalk...
June 21, 2023: Neuropediatrics
https://read.qxmd.com/read/37329878/language-delay-in-patients-with-cln2-disease-could-it-support-earlier-diagnosis
#66
JOURNAL ARTICLE
Miriam Nickel, Paul Gissen, Rebecca Greenaway, Simona Cappelletti, Christiane Hamborg, Benedetta Ragni, Tanja Ribitzki, Angela Schulz, Ilaria Tondo, Nicola Specchio
Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is a rare pediatric disorder associated with rapid neurodegeneration, and premature death in adolescence. An effective enzyme replacement therapy (cerliponase alfa) has been approved that can reduce this predictable neurological decline. The nonspecific early symptoms of CLN2 disease frequently delay diagnosis and appropriate management. Seizures are generally recognized as the first presenting symptom of CLN2 disease, but emerging data show that language delay may precede this...
June 17, 2023: Neuropediatrics
https://read.qxmd.com/read/37321252/quality-of-life-in-children-and-adolescents-with-neurofibromatosis-type-1-a-single-center-observational-study
#67
JOURNAL ARTICLE
Sarah Hofmann, Sandra Winkler, Matthias Baumann, Herta Zellner
This article obtains an overview of the health status of children and adolescents with neurofibromatosis type 1 (NF1) with a focus on the clinical course of the disease, neuropsychodiagnostic findings, and their impact on quality of life (QoL).In this observational study, data were collected from 24 children and adolescents with NF1 who were cared for at the University Hospital in Innsbruck, Austria, from 2008 to 2022. Data were collected every 6 to 12 months from routine check-ups, including clinical features and imaging findings...
June 15, 2023: Neuropediatrics
https://read.qxmd.com/read/37321251/communal-poverty-is-a-significant-risk-factor-for-neonatal-seizures
#68
JOURNAL ARTICLE
Osama Tanous, Kholoud T Haj-Yahya, Angie Ershead, Liat Lerner
INTRODUCTION:  Neonatal seizures (NS) are a severe condition with significant mortality and long-term morbidity. This study aims to identify risk factors for NS in a racially or ethnically diverse population in Israel. METHODS:  This is a case-control study. The cases were all newborns born between 2001 and 2019 at Emek Medical Center in Israel and admitted with NS. Two healthy controls born in the same period were matched for each case. Demographic, maternal, and neonatal variables were abstracted from the electronic medical files...
June 15, 2023: Neuropediatrics
https://read.qxmd.com/read/37321250/ketogenic-diet-in-neonates-with-drug-resistant-epilepsy-efficacy-and-side-effects-a-single-center-s-initial-experience
#69
JOURNAL ARTICLE
Raffaele Falsaperla, Vincenzo Sortino, Ausilia Desiree Collotta, Grete Francesca Privitera, Antonio Palmeri, Laura Mauceri, Martino Ruggieri
BACKGROUND:  For patients with pharmacoresistant epilepsy, a therapeutic option is ketogenic diet. Currently, data on young infants are scarce, particularly during hospitalization in the neonatal intensive care unit (NICU). OBJECTIVE:  The aim of the present study was to evaluate the short-term (3-month) efficacy and side effects of ketogenic diet in infants with "drugs-resistant" epilepsy treated during NICU stay. METHODS:  This retrospective study included infants aged under 2 months started on ketogenic diet during NICU hospitalization to treat drug-resistant epilepsy from April 2018 to November 2022...
June 15, 2023: Neuropediatrics
https://read.qxmd.com/read/36827993/efficacy-of-melatonin-for-insomnia-in-children-with-autism-spectrum-disorder-a-meta-analysis
#70
JOURNAL ARTICLE
Mei Xiong, Fang Li, Zhaohua Liu, Xin Xie, Hongli Shen, Weiteng Li, Liping Wei, Rongfang He
AIM: This study aimed to evaluate the effectiveness of melatonin in treating insomnia in children with autism spectrum disorder (ASD). METHODS: Comprehensive searches were conducted in the PubMed, EMBASE, and Web of Science databases from their inception to April 20, 2022. Data were extracted and assessed for quality by two researchers. Statistical analysis was performed using the Stata 15.0 software. RESULTS: Four studies including 238 patients were included...
June 2023: Neuropediatrics
https://read.qxmd.com/read/36539215/clinical-outcome-data-of-children-treated-with-cannabis-based-medicinal-products-for-treatment-resistant-epilepsy-analysis-from-the-uk-medical-cannabis-registry
#71
JOURNAL ARTICLE
Simon Erridge, Carl Holvey, Ross Coomber, Jonathan Hoare, Shaheen Khan, Michael W Platt, James J Rucker, Mark W Weatherall, Sushil Beri, Mikael H Sodergren
BACKGROUND: There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment of treatment-resistant epilepsy (TRE) in children. METHODS: A case series of children (<18 years old) with TRE from the UK Medical Cannabis Registry was analyzed. Primary outcomes were ≥50% reduction in seizure frequency, changes in the Impact of Pediatric Epilepsy Score (IPES), and incidence of adverse events. RESULTS: Thirty-five patients were included in the analysis...
June 2023: Neuropediatrics
https://read.qxmd.com/read/37257496/early-muscle-mri-findings-in-a-pediatric-case-of-emery-dreifuss-muscular-dystrophy-type-1
#72
JOURNAL ARTICLE
Chiara Panicucci, Sara Casalini, Monica Traverso, Noemi Brolatti, Serena Baratto, Lizzia Raffaghello, Marina Pedemonte, Luca Doglio, Maria Derchi, Giorgio Tasca, Beatrice M Damasio, Chiara Fiorillo, Claudio Bruno
Emery-Dreifuss muscular dystrophy (EDMD) is a rare disease characterized by early contractures, progressive muscle weakness, and cardiac abnormalities. Different subtypes of EDMD have been described, with the two most common forms represented by the X-linked EDMD1, caused by mutations in the EMD gene encoding emerin, and the autosomal EDMD2, due to mutations in the LMNA gene encoding lamin A/C. A clear definition of the magnetic resonance imaging (MRI) pattern in the two forms, and especially in the rarer EDMD1, is still lacking, although a preferential involvement of the medial head of the gastrocnemius has been suggested in EDMD2...
May 31, 2023: Neuropediatrics
https://read.qxmd.com/read/37164316/myoclonic-status-epilepticus-in-tbc1d24-related-dee
#73
JOURNAL ARTICLE
Ranjith Kumar Manokaran, Jaina Patel, Suvasini Sharma, Ayako Ochi, Puneet Jain
No abstract text is available yet for this article.
May 10, 2023: Neuropediatrics
https://read.qxmd.com/read/37164315/anterior-spinal-artery-syndrome-due-to-fibrocartilaginous-embolism-case-report-and-treatment-options
#74
JOURNAL ARTICLE
Christian Menke, Ivonne Wieland, Eva Bueltmann, Sabine Illsinger, Hans Hartmann
INTRODUCTION: Acute occlusion of the anterior spinal artery and subsequent spinal ischemic infarction lead to anterior spinal artery syndrome characterized by back pain and bilateral flaccid paresis with loss of protopathic sensibility. As a rare cause fibrocartilaginous embolism has been described and is associated with sports or unusual strain. CASE REPORT: Following gymnastic exercise the day before symptom-onset, the 11 y.o. girl presented with neck pain, paresis of arms and legs and impaired deep tendon reflexes...
May 10, 2023: Neuropediatrics
https://read.qxmd.com/read/37054976/clinical-significance-of-diffusion-tensor-imaging-in-metachromatic-leukodystrophy
#75
JOURNAL ARTICLE
Lucas Bastian Amedick, Pascal Martin, Judith Beschle, Manuel Strölin, Marko Wilke, Nicole Wolf, Petra Pouwels, Gisela Hagberg, Uwe Klose, Thomas Naegele, Ingeborg Kraegeloh-Mann, Samuel Groeschel
BACKGROUND AND PURPOSE: Metachromatic leukodystrophy (MLD) is a lysosomal enzyme deficiency disorder leading to progressive demyelination and, consecutively, to cognitive and motor decline. Brain MRI can detect affected white matter as T2 hyperintense but cannot quantify the gradual microstructural process of demyelination more accurately. Our study aimed to investigate the value of routine MR diffusion tensor imaging in assessing disease progression. MATERIALS AND METHODS: MR diffusion parameters (ADC and FA) were in the frontal white matter (FWM), central region (CR) and posterior limb of the internal capsule (PLIC) in 111 MR data sets from a natural history study of 83 patients (age 0...
April 13, 2023: Neuropediatrics
https://read.qxmd.com/read/37019145/five-years-follow-up-of-opsoclonus-myoclonus-ataxia-syndrome-associated-neurogenic-tumors-in-children
#76
JOURNAL ARTICLE
Elif Habibe Aktekin, Hasan Özkan Gezer, Nalan Yazıcı, İlknur Erol, Ayşe Erbay, Faik Sarıalioğlu
AIM:  Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare autoimmune disorder. Approximately half of the cases are associated with neuroblastoma in children. This study's aim is to review management of our cases with OMAS-associated neuroblastoma for treatment approach as well as long-term follow-up. METHODS:  Age at onset of symptoms and tumor diagnosis, tumor location, histopathology, stage, chemotherapy, OMAS protocol, surgery, and follow-up period were evaluated retrospectively in six patients between 2007 and 2022...
April 5, 2023: Neuropediatrics
https://read.qxmd.com/read/36914163/subdural-hemorrhage-as-an-early-presentation-in-a-case-of-sotos-syndrome
#77
JOURNAL ARTICLE
Tomoki T Nomakuchi, Cesar Augusto P Alves, Lauren A Beslow, Deborah Zarnow, Neera Goyal, Elaine H Zackai, Francis Jeshira Reynoso Santos
Subdural hemorrhages (SDHs) in the pediatric population are associated with a high mortality and morbidity and may present in the context of abusive head trauma. Diagnostic investigations for such cases often include evaluation for rare genetic and metabolic disorders that can have associated SDH. Sotos syndrome is an overgrowth syndrome associated with macrocephaly and increased subarachnoid spaces and rarely with neurovascular complications. Here, we report two cases of Sotos syndrome, one with SDH during infancy who underwent repeated evaluation for suspected child abuse prior to the Sotos syndrome diagnosis and the other with enlarged extra-axial cerebrospinal fluid spaces, demonstrating a possible mechanism for SDH development in this setting...
April 5, 2023: Neuropediatrics
https://read.qxmd.com/read/36878222/the-coexistence-of-two-genetic-astrocytopathies-megalencephalic-leukoencephalopathy-and-vanishing-white-matter-disease-in-an-indian-child
#78
JOURNAL ARTICLE
Suman Das, Biman Kanti Ray, Uddalak Chakraborty, Jayakrishna Tippabathani, Arindam Santra
A 9-month-old male child, born of second-degree consanguinity, presented with a progressively enlarging head since early infancy. The child had normal early development, but further acquisition of milestones after 6 months was delayed. He had afebrile seizures at 9 months, followed by the appearance of appendicular spasticity. First magnetic resonance imaging (MRI) showed nonenhancing, diffuse, bilaterally symmetrical T1/fluid-attenuated inversion recovery (FLAIR) hypointensity and T2 hyperintensity of the cerebral white matter and anterior temporal cysts...
April 2023: Neuropediatrics
https://read.qxmd.com/read/36809795/differences-in-tic-severity-among-adolescent-girls-and-boys-with-tourette-syndrome-during-the-pandemic
#79
JOURNAL ARTICLE
Travis R Larsh, Steve W Wu, David A Huddleston, Tara D Lipps, Donald L Gilbert
OBJECTIVE:  Limited data are available regarding the impact of the coronavirus disease 2019 (COVID-19) pandemic on adolescents with Tourette syndrome (TS). We sought to compare sex differences in tic severity experienced by adolescents before and during the COVID-19 pandemic. METHODS:  We extracted from the electronic health record and retrospectively reviewed Yale Global Tic Severity Scores (YGTSS) from adolescents (ages 13 through 17) with TS presenting to our clinic before (36 months) and during (24 months) the pandemic...
March 24, 2023: Neuropediatrics
https://read.qxmd.com/read/36921608/family-burden-and-epilepsy-surgery-in-children-with-drug-resistant-epilepsy
#80
JOURNAL ARTICLE
Sebastian Hoyer, Konstantin L Makridis, Deniz A Atalay, Ulrich-W Thomale, Christine Prager, Christian E Elger, Angela M Kaindl
INTRODUCTION:  Family burden (FB) in pediatric patients with drug-resistant epilepsy (DRE) is significantly higher than that in children with non-DRE. Epilepsy surgery is an established approach to treat DRE, and this study examines the impact of pediatric epilepsy surgery on FB. METHODS:  We retrospectively analyzed data of families and pediatric patients with focal structural DRE treated with epilepsy surgery at our epilepsy center from April 2018 to November 2021...
March 15, 2023: Neuropediatrics
journal
journal
28093
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.